Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial - Concepedia

Concepedia

Publication | Closed Access

Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial

166

Citations

9

References

2019

Year

Inge B. Halberg, Karsten Lyby, Karsten Wassermann, Tim Heise, Eric Zijlstra, Leona Plum‐Mörschel

The Lancet Diabetes & Endocrinology

Subcutaneous Insulin GlargineDiabetes ManagementInsulin ManagementDiabetesType 2Oral Basal InsulinDiabetes MellitusInsulin DeliveryMedicine

References

	Year	Citations

Page 1